首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷內視鏡檢查設備

市場調查報告書

商品編碼

1439367

全球支氣管鏡市場：洞察、競爭格局、市場預測：2030 年

Bronchoscope - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 按訂單生產 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

2023年，全球支氣管鏡市場規模達191.4億美元。預計到 2030 年，市場規模將達到 293.8 億美元，2024 年至 2030 年的預測期間複合年增長率為 7.46%。支氣管鏡市場受到結核病等各種呼吸系統疾病患病率上升、肺癌新興市場擴張、慢性阻塞性肺病病例增加以及與其他支氣管鏡相關的產品開發活動增加等因素的推動，這些因素見證了市場的強勁增長。

支氣管鏡市場的主要驅動因素之一是結核病等各種呼吸道疾病的盛行率不斷上升。根據世界衛生組織（WHO）提供的情況說明書，2020年全球約有1,000萬人感染結核病。此外，根據同一份文件，結核病是僅次於 COVID-19 的第二大死因，該疾病在 2020 年奪走了約 150 萬人的生命。許多研究報告稱，當懷疑結核病時，通常建議在塗片檢查呈陰性後進行支氣管鏡檢查作為確診檢查。此外，已確定，在治療結核病相關狹窄方面，支氣管鏡手術被認為是比傳統手術侵入性較小的治療策略。因此，結核病患者病率的上升預計將增加對支氣管鏡的需求，並對預測期內支氣管鏡市場的成長產生積極影響。

該報告研究了全球支氣管鏡市場，並提供了市場概況，包括產品類型、柔軟度、用途、最終用戶、區域趨勢以及參與市場的公司概況。

Boston Scientific Corporation
Ambu Inc
Olympus
Richard Wolf GmbH
Karl Storz GmbH
FUJIFILM Corporation
PENTAX Medical (HOYA Corporation)
Teleflex Incorporated
Innovex Medical Co., Ltd
Zhuhai Seesheen Medical Technology Co.,Ltd
EMOS Technology GmbH
Optomic
Clarus Medical LLC
The Surgical Company
Hunan Vathin Medical Instrument Co., Ltd.
Aohua Endoscopy Co., Ltd
Lymol Medical
Verathon Inc
Novatech SA
NeoScope Inc

第10章項目方法

第11章 KOL觀點

第12章 DelveInsight服務內容

第13章免責聲明

第 14 章關於 DelveInsight

簡介目錄圖表

Product Code: DIMDCL0163

Bronchoscopes Market By Product Type (Rigid Bronchoscopes, Flexible Fiber Bronchoscopes, Flexible Video Bronchoscopes, And Mobile Bronchoscopes), By Flexibility (Flexible And Rigid), By Usability (Single-Use And Reusable) By End User (Hospitals, Specialty Clinics, And Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to rising prevalence of various respiratory diseases such as tuberculosis and lung cancers.

Global bronchoscopes market was valued at USD 19.14 billion in 2023, growing at a CAGR of 7.46% during the forecast period from 2024 to 2030 to reach USD 29.38 billion by 2030. The bronchoscopes market is witnessing a positive market growth owing to the factors such as rising prevalence of various respiratory diseases such as tuberculosis, growing prevalence of lung cancers, increasing cases of chronic obstructive pulmonary diseases, and increasing product development activities with respect to bronchoscopes among others.

Bronchoscopes Market Dynamics:

One of the main drivers of the bronchoscopes market is the rising prevalence of various respiratory diseases such as tuberculosis (TB). According to the factsheet provided by the World Health Organization (WHO), in 2020, approximately 10 million people were infected with tuberculosis across the globe. Moreover, the same source stated that tuberculosis was the second leading cause of death after COVID-19 claiming near about 1.5 million lives in 2020. It has been reported in many studies that bronchoscopy is often recommended in patients as a confirmatory test with a negative smear test result for suspected tuberculosis. Moreover, it has also been established that bronchoscopic procedures are considered to be less invasive therapeutic strategies than conventional surgery in the management of TB-related stenosis. Therefore, the demand for bronchoscopes is set to witness an increase owing to the increasing prevalence of tuberculosis, thereby positively impacting the bronchoscopes market growth during the forecast period.

Another key factor responsible for the growth of the bronchoscopes market is the rising prevalence of lung cancer. As per the data provided by the GLOBOCAN 2020 study cited by the WHO, in 2020, lung cancer was the second most diagnosed cancer type with 2,206,771 new cases across the globe. In addition to that, lung cancer was the leading cause of death among all cancer types accounting for 1,796,144 deaths globally. It has been established that bronchoscopy is the primary procedure conducted in order to collect a biopsy sample for the diagnosis of lung cancer. Moreover, bronchoscopy has proven to be helpful in detecting precancerous lesions associated with lung cancer thereby helping in the early cancer diagnosis. Hence, the rising prevalence of lung cancer as well as benefits of bronchoscopy in lung cancer diagnosis are expected to contribute in the growing demand for bronchoscopes, thereby supporting the growth of the bronchoscopes market during the forecast period.

Along with the factors mentioned above, technological advancements in the field of bronchoscopy such as the development of new bronchoscopic techniques such as autofluorescence bronchoscopy (AFB) and high magnification bronchovideoscopy (HMB) among others with the aim to enhance the yield and diagnostic accuracy are also expected to aid in the growth of the bronchoscopes market.

However, complications associated with bronchoscopy and risk of infection associated with reusable bronchoscopes may be certain limiting factors of the bronchoscopes market growth.

Moreover, the impact of the COVID-19 pandemic remained neutral on the bronchoscopes market. Many major organizations across the world issued guidelines regarding the conducting of bronchoscopy in patients with respiratory illnesses. Bronchoscopy was contraindicated in patients with a positive COVID-19 test result as there is generation of aerosols during bronchoscopy which may put other patients and healthcare workers at risk. However, bronchoscopy was deemed an essential procedure in events of complications such as atelectasis or haemoptysis, issues with mechanical ventilation, and to rule out complications associated with COVID-19. Therefore, the market for bronchoscopes maintained a neutral growth rate during the COVID-19 pandemic.

Bronchoscopes Market Segment Analysis:

Bronchoscopes Market by Product Type (Rigid Bronchoscopes, Flexible Fiber Bronchoscopes, Flexible Video Bronchoscopes, and Mobile Bronchoscopes), by Flexibility (Flexible and Rigid), by Usability (Single-Use and Reusable) by End User (Hospitals, Specialty Clinics, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the flexibility segment of bronchoscopes market, the flexible bronchoscopes are estimated to hold a higher share in the bronchoscopes market during the forecast period. This can be attributed to the specific features associated with these devices. Owing to their flexible nature, flexible bronchoscopes are much easier to place inside the body where frequent repositioning of the bronchoscopes is required in order to obtain a clear image. Moreover, flexible bronchoscopes can be employed in both diagnostic and therapeutic procedures. Another added advantage associated with flexible bronchoscopes is that they can be used to access both the upper and lower airways while rigid bronchoscopes are mostly restricted to upper-airway applications. Therefore, considering the advantages associated with flexible bronchoscopes, this product category is expected to generate significant revenue share eventually contributing the overall growth of the global bronchoscopes market in the forecast period.

North America is expected to dominate the Overall Bronchoscopes Market:

Among all the regions, North America is expected to account for the largest share in the global Bronchoscopes market. Factors such as rising prevalence of chronic obstructive pulmonary disease, increasing prevalence of various cancers including lung cancers, rising government initiatives, and increased product launches are expected to aid in the growth of the North America Bronchoscopes Market. Furthermore, high disposable income, sophisticated healthcare infrastructure, and increased awareness regarding disease progression and new treatments are also expected to aid in the bronchoscopes market growth in this region.

As per the data provided by the Centers for Disease Control and Prevention, as of 2022, approximately 16 million people in the United States suffer from chronic obstructive pulmonary disease (COPD) and variations associated with it such as chronic bronchitis and emphysema. Additionally, according to the data provided by the American Lung Association, in 2018, 156,045 people succumbed to COPD, making it the fourth overall leading cause of death behind heart disease, cancer, and accidents and unintentional injuries in the United States. COPD and its exacerbations result in airflow limitation, hyperinflation and reduced gas exchange which are often treated with devices such as endobronchial valves (EBV), endobronchial stents, and endobronchial coils (EBC) that are placed using bronschoscopes to open up the restricted airway. Therefore, the rising prevalence of COPD in the country would result in the rising demand for treatments that make use of bronchoscopes, which in turn would provide a conducive growth environment for the United States bronchoscopes market as well as the North American region.

Furthermore, the increased emphasis on product development activities and high interest of device manufacturers in accessing local markets further aid in the growth of the regional markets for bronchoscopes. For instance, in June 2022, Ambu Inc. received the product approval from the US Food and Drug Administration for their single-use bronchoscope and sample collection system. The product launches in the local markets correlate to a significant reduction in costs thereby making them affordable for end users which in turn drives the product demand in the market. Therefore, the interplay of various factors such as the presence of large patient population, encouraging reimbursement policies as well as new product launches in the region are expected to boost the North America bronchoscopes market during the forecast period.

Bronchoscopes Market Key Players:

Some of the key market players operating in the bronchoscopes market includes Boston Scientific Corporation, Ambu Inc, Olympus, Richard Wolf GmbH, Karl Storz, FUJIFILM Corporation, PENTAX Medical (HOYA Corporation), Teleflex Incorporated, Innovex Medical Co., Ltd, Zhuhai Seesheen Medical Technology Co.,Ltd, EMOS Technology GmbH, Optomic., Clarus Medical LLC, The Surgical Company., Hunan Vathin Medical Instrument Co., Ltd., Aohua Endoscopy Co., Ltd, Verathon, Inc., Lymol Medical, Novatech SA, NeoScope Inc and others.

Recent Developmental Activities in Bronchoscopes Market:

In August 2022, Boston Scientific Corporation received the product approval from the US Food and Drug Administration for their EXALT Model B Single-Use Bronchoscope.

In May 2022, Boston Scientific Corporation received the CE mark approval for their EXALT Model B Single-Use Bronchoscope.

In April 2022, Olympus announced the launch of their new line of five single-use bronchoscopes in the global markets.

Key Takeaways from the Bronchoscopes Market Report Study

Market size analysis for current bronchoscopes market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the bronchoscopes market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the global bronchoscopes market.

Various opportunities available for the other competitor in the bronchoscopes market space.

What are the top performing segments in 2023? How these segments will perform in 2030.

Which is the top-performing regions and countries in the current bronchoscopes market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for bronchoscopes market growth in the coming future?

Target Audience who can be benefited from this Bronchoscopes Market Report Study

Bronchoscopes products providers

Research organizations and consulting companies

Bronchoscopes-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in bronchoscopes

Various End-users who want to know more about the bronchoscopes market and latest technological developments in the bronchoscopes market.

Frequently Asked Questions for Bronchoscopes Market:

1. What is a Bronchoscope?

A bronchoscope is a device that is used in the visualization of internal anatomy of lungs.

2. What is the market for Global Bronchoscopes?

Global bronchoscopes market was valued at USD 19.14 billion in 2023, growing at a CAGR of 7.46% during the forecast period from 2024 to 2030 to reach USD 29.38 billion by 2030.

3. What are the drivers for Global Bronchoscopes Market?

The bronchoscopes market is witnessing a positive market growth owing to the factors such as rising prevalence of various respiratory diseases such as COVID-19 and lung cancers, increasing pneumonia cases in children, and increasing product development activities with respect to bronchoscopes among others.

4. Who are the key players operating in Global Bronchoscopes Market?

5. Which region has the highest share in Bronchoscopes Market?

North America is expected to hold the highest share in the revenue in the Bronchoscopes market during the forecast period. Factors such as rising prevalence of chronic obstructive pulmonary disease, increasing prevalence of various cancers including lung cancers, rising government initiatives, and increased product launches are expected to aid in the growth of the North America Bronchoscopes Market. Furthermore, high disposable income, sophisticated healthcare infrastructure, and increased awareness regarding disease progression and new treatments are also expected to aid in the bronchoscopes market growth in this region. .

1.Bronchoscopes Market Report Introduction

2.Bronchoscopes Market Executive Summary

2.1 Scope of the Study
2.2 Market at Glance
2.3 Competitive Assessment
2.4 Financial Benchmarking

3. Regulatory and Patent Analysis

3.1 The United States
3.2 Europe
- 3.2.1 Germany
- 3.2.2 France
- 3.2.3 Italy
- 3.2.4 Spain
- 3.2.5 U.K.
3.3 Japan

4. Bronchoscopes Market Key Factors Analysis

4.1 Bronchoscopes Market Drivers
- 4.1.1 Increasing Prevalence of Respiratory Diseases
- 4.1.2 Rising Prevalence of Lung Cancer
- 4.1.3 Technological Advancements in Product Development
4.2 Bronchoscopes Market Restraints and Challenges
- 4.2.1 Bronchoscopy-Related Procedural Complications
- 4.2.2 Risk of Infection Associated With Reusable Bronchoscopes
4.3 Bronchoscopes Market Opportunities
- 4.3.1 Improving on the Product Design
- 4.3.2 Targeting Emerging Markets for Product Launches

5. Bronchoscopes Market Porter's Five Forces Analysis

5.1 Bargaining Power of Suppliers
5.2 Bargaining Power of Consumers
5.3 Threat of New Entrants
5.4 Threat of Substitutes
5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Bronchoscopes Market

7. Bronchoscopes Market Layout

7.1 By Product Type
- 7.1.1 Rigid Bronchoscopes
- 7.1.2 Flexible Fiber Bronchoscopes
- 7.1.3 Flexible Video Bronchoscopes
- 7.1.4 Mobile Bronchoscopes
7.2 By Flexibility
- 7.2.1 Flexible Bronchoscopes
- 7.2.2 Rigid Bronchoscopes
7.3 By Usability
- 7.3.1 Single-Use Bronchoscopes
- 7.3.2 Reusable Bronchoscopes
7.4 By End User
- 7.4.1 Hospitals
- 7.4.2 Specialty Clinics
- 7.4.3 Others
7.5 By Geography
- 7.5.1 North America
  - 7.5.1.1 North America Bronchoscopes Market, by Product Type
  - 7.5.1.2 North America Bronchoscopes Market, by Flexibility
  - 7.5.1.3 North America Bronchoscopes Market, by Usability
  - 7.5.1.4 North America Bronchoscopes Market, by End User
  - 7.5.1.5 North America Bronchoscopes Market, by Country
  - 7.5.1.3.1 United States
  - 7.5.1.3.2 Canada
  - 7.5.1.3.3 Mexico
- 7.5.2 Europe
  - 7.5.2.1 Europe Bronchoscopes Market, by Product Type
  - 7.5.2.2 Europe Bronchoscopes Market, by Flexibility
  - 7.5.2.3 Europe Bronchoscopes Market, by Usability
  - 7.5.2.4 Europe Bronchoscopes Market, by End User
  - 7.5.2.5 Europe Bronchoscopes Market, by Country
  - 7.5.2.3.1 France
  - 7.5.2.3.2 Germany
  - 7.5.2.3.3 United Kingdom
  - 7.5.2.3.4 Italy
  - 7.5.2.3.5 Spain
  - 7.5.2.3.6 Russia
  - 7.5.2.3.7 Rest of Europe
- 7.5.3 Asia-Pacific
  - 7.5.3.1 Asia-Pacific Bronchoscopes Market, by Product Type
  - 7.5.3.2 Asia-Pacific Bronchoscopes Market, by Flexibility
  - 7.5.3.3 Asia-Pacific Bronchoscopes Market, by Usability
  - 7.5.3.4 Asia-Pacific Bronchoscopes Market, by End User
  - 7.5.3.5 Asia-Pacific Bronchoscopes Market, by Country
  - 7.5.3.3.1 China
  - 7.5.3.3.2 Japan
  - 7.5.3.3.3 India
  - 7.5.3.3.4 Australia
  - 7.5.3.3.5 South Korea
  - 7.5.3.3.6 Rest of Asia Pacific
- 7.5.4 Rest of the World (RoW)
  - 7.5.4.1 RoW Bronchoscopes Market, by Product Type
  - 7.5.4.2 RoW Bronchoscopes Market, by Flexibility
  - 7.5.4.3 RoW Bronchoscopes Market, by Usability
  - 7.5.4.4 RoW Bronchoscopes Market, by End User
  - 7.5.4.5 RoW Bronchoscopes Market, by Region
  - 7.5.4.3.1 Middle East
  - 7.5.4.3.2 Africa
  - 7.5.4.3.3 South America

8. Bronchoscopes Market Global Company Share Analysis - Key 3-5 Companies

9. Bronchoscopes Market Company and Product Profiles

9.1 Boston Scientific Corporation
- 9.1.1. Company Overview
- 9.1.2. Company Snapshot
- 9.1.3. Financial Overview
- 9.1.4 Product Listing
- 9.1.5. Entropy
9.2 Ambu Inc
- 9.2.1. Company Overview
- 9.2.2. Company Snapshot
- 9.2.3. Financial Overview
- 9.2.4 Product Listing
- 9.2.5. Entropy
9.3 Olympus
- 9.3.1. Company Overview
- 9.3.2. Company Snapshot
- 9.3.3. Financial Overview
- 9.3.4 Product Listing
- 9.3.5. Entropy
9.4 Richard Wolf GmbH
- 9.4.1. Company Overview
- 9.4.2. Company Snapshot
- 9.4.3. Financial Overview
- 9.4.4 Product Listing
- 9.4.5. Entropy
9.5 Karl Storz GmbH
- 9.5.1. Company Overview
- 9.5.2. Company Snapshot
- 9.5.3. Financial Overview
- 9.5.4 Product Listing
- 9.5.5. Entropy
9.6 FUJIFILM Corporation
- 9.6.1. Company Overview
- 9.6.2. Company Snapshot
- 9.6.3. Financial Overview
- 9.6.4 Product Listing
- 9.6.5. Entropy
9.7 PENTAX Medical (HOYA Corporation)
- 9.7.1. Company Overview
- 9.7.2. Company Snapshot
- 9.7.3. Financial Overview
- 9.7.4 Product Listing
- 9.7.5. Entropy
9.8 Teleflex Incorporated
- 9.8.1. Company Overview
- 9.8.2. Company Snapshot
- 9.8.3. Financial Overview
- 9.8.4 Product Listing
- 9.8.5. Entropy
9.9 Innovex Medical Co., Ltd
- 9.9.1. Company Overview
- 9.9.2. Company Snapshot
- 9.9.3. Financial Overview
- 9.9.4 Product Listing
- 9.9.5. Entropy
9.10 Zhuhai Seesheen Medical Technology Co.,Ltd
- 9.10.1. Company Overview
- 9.10.2. Company Snapshot
- 9.10.3. Financial Overview
- 9.10.4 Product Listing
- 9.10.5. Entropy
9.11 EMOS Technology GmbH
- 9.11.1. Company Overview
- 9.11.2. Company Snapshot
- 9.11.3. Financial Overview
- 9.11.4 Product Listing
- 9.11.5. Entropy
9.12 Optomic
- 9.12.1. Company Overview
- 9.12.2. Company Snapshot
- 9.12.3. Financial Overview
- 9.12.4 Product Listing
- 9.12.5. Entropy
9.13 Clarus Medical LLC
- 9.13.1. Company Overview
- 9.13.2. Company Snapshot
- 9.13.3. Financial Overview
- 9.13.4 Product Listing
- 9.13.5. Entropy
9.14 The Surgical Company
- 9.14.1. Company Overview
- 9.14.2. Company Snapshot
- 9.14.3. Financial Overview
- 9.14.4 Product Listing
- 9.14.5. Entropy
9.15 Hunan Vathin Medical Instrument Co., Ltd.
- 9.15.1. Company Overview
- 9.15.2. Company Snapshot
- 9.15.3. Financial Overview
- 9.15.4 Product Listing
9.16 Aohua Endoscopy Co., Ltd
- 9.16.1. Company Overview
- 9.16.2. Company Snapshot
- 9.16.3. Financial Overview
- 9.16.4 Product Listing
- 9.16.5. Entropy
9.17 Lymol Medical
- 9.17.1. Company Overview
- 9.17.2. Company Snapshot
- 9.17.3. Financial Overview
- 9.17.4 Product Listing
- 9.17.5. Entropy
9.18 Verathon Inc
- 9.18.1. Company Overview
- 9.18.2. Company Snapshot
- 9.18.3. Financial Overview
- 9.18.4 Product Listing
- 9.18.5. Entropy
9.19 Novatech SA
- 9.19.1. Company Overview
- 9.19.2. Company Snapshot
- 9.19.3. Financial Overview
- 9.19.4 Product Listing
- 9.19.5. Entropy
9.20 NeoScope Inc
- 9.20.1. Company Overview
- 9.20.2. Company Snapshot
- 9.20.3. Financial Overview
- 9.20.4 Product Listing
- 9.20.5. Entropy